1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1:

Clinical data for 8 patients with imaging changes after proton therapy

PatientSexDiagnosisLocationAge at Diagnosis (yr)Age at Proton Therapy (yr)
    1FEPFourth ventricle1.72.2
    2MEPFourth ventricle1.92.4
    3FCPCLeft lateral ventricle1.22.6
    4FPNETLeft parietal lobe2.73.2
    5FMBFourth ventricle11.4
    6FEPFourth ventricle33.5
    7FAT/RTPosterior fossa0.61
    8MEPFourth ventricle2.22.6
Median1.82.5
Mean1.82.4
  • Note:—EP indicates ependymoma; MB, medulloblastoma.